IBSA is one of the world leaders in the production of hyaluronic acid by biofermentation.
Over the years, it has focused its efforts on developing increasingly innovative products in order to best meet the therapeutic needs of physicians and patients in a diversified way: this has led to the birth of three different generations of hyaluronic acid.
The first generation contains single-molecular-weight LINEAR HYALURONIC ACID, which is ultra-pure, biofermentative and not chemically modified and is therefore highly biocompatible.
In this category, the company has developed products with ever-increasing concentrations, from 0.8% to 2%, a maximum concentration above which it would be difficult to ensure easy extrusion of the product from the syringe during use.